Quarter Financials
Supernus Pharmaceuticals, Inc. (SUPN)
$35.59
+0.14 (+0.39%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Net Income | 25 | 2 | 8 | 26 | 2 | 22 | 24 | 6 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | 481 | 456 | 454 | 446 | 380 | 377 | 356 | 332 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| Capital Expenditure | 1 | -0 | - | -1 | -0 | -0 | - | -2 |
|---|
| Net PPE | 15 | 16 | 16 | 17 | 17 | 16 | 17 | 38 |
|---|
|
Year
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
|---|
| New Purchases | -119 | -114 | -74 | -4 | -98 | -108 | -341 | 140 |
|---|
| Intangible and Goodwill | 78 | 78 | 78 | 118 | 115 | 115 | 117 | 117 |
|---|